Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 1, 2026 · Leadership change · Item 5.01 · Investor press release · +1 more
WEST PHARMACEUTICAL SERVICES INC
34
Leadership change
Jun 1, 2026
| ItemItem | Disclosure |
|---|---|
| Item 5.01 | Item 5.01 |
| Item 5.02 | Director or executive officer departure or appointment |
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
| Item 9.01 | Financial statements and exhibits |
WEST PHARMACEUTICAL SERVICES INC filed this to disclose a change in directors or executive officers appointments, departures, or role changes that can signal a strategic shift.
Investor Contact: Media Contact: John Sweeney, CFA Michele Polinsky Vice President, Investor Relations Vice President, Global Communications +1-484-790-0373 +1-610-594-3054 John. com West Appoints Michel Lagarde to be President and Chief Executive Officer Experienced healthcare and life sciences executive to lead the Company’s next phase of growth and innovation EXTON, Pa.
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
WEST PHARMACEUTICAL SERVICES INC reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
